News for Terns Pharmaceuticals, Inc. (TERN)

TERN-701 CARDINAL study progressing well; dose expansion expected to initiate in 2Q25 with additional safety and efficacy data in 4Q25 New TERN-701 data from o

**media[549781]**

Seasoned public company CFO with 25 years of leadership experience in biotech FOSTER CITY, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals,

**media[546129]**

On December 31, 2024, Citadel Advisors LLC (Trades, Portfolio) executed a significant transaction involving Terns Pharmaceuticals Inc (NASDAQ: TERN). The firm r

Transaction Overview On December 31, 2024, Schonfeld Strategic Advisors LLC (Trades, Portfolio) made a significant addition to its holdings in Terns Pharmaceuti

**media[531122]**

GENFIT signs royalty financing deal with HealthCare Royalty (HCRx) providing up to €185 million non-dilutive capital:  €130 million upfront, with eligibility to receive up to €55 million in two additional instalments based on near-term milestonesClosing subject to approval by the 2025 OCEANE bondholders at upcoming bondholders meetingFinancing would extend cash runway beyond the end of 2027, assuming drawdown of all instalmentsProceeds to further strengthen the development of the ACLF pipeline

Allurion stock soars on weight-loss therapy update. Stardust Power breaks ground on Oklahoma lithium refinery. OpenAI launches shopping agent Operator; Etsy, eBay tick higher.

**media[510093]**

Terns Pharmaceuticals' chief medical officer sells $25,607 in stock

Terns Pharmaceuticals CFO Mark J. Vignola sells $99,022 in stock

FOSTER CITY, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (”œTerns” or the ”œCompany”) ( TERN), a clinical-stage biopharmaceuti

**media[504479]**

We recently compiled a list of the 12 Best Weight Loss Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Terns Pharmaceuticals, Inc.

Most people have at some point sought to include weight loss and physical exercise in their daily life.

**media[481930]**

Compelling molecular responses starting at lowest dose level in heavily pre-treated patients with high baseline BCR-ABL transcript levels Encouraging safety pr

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a...